Reduced Fractionation in Lung Cancer Patients Treated with Curative-intent Radiotherapy during the COVID-19 Pandemic

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

Scott Antonia, Augusto Villegas, Davey B. Daniel et al. · New England Journal of Medicine · 2018 · 2.8K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and Etoposide

Andrew T. Turrisi, KyungMann Kim, Ronald H. Blum et al. · New England Journal of Medicine · 1999 · 1.5K citations · Full text

Medicine, Oncology, Radiation Oncology +11

Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.

Nevin Murray, P. Coy, Joseph L. Pater et al. · Journal of Clinical Oncology · 1993 · 728 citations

Medicine, Oncology, Radiation Oncology +14

Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial

Corinne Faivre‐Finn, M. Snee, Linda Ashcroft et al. · The Lancet Oncology · 2017 · 570 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline

Gregory M.M. Videtic, Jessica Donington, Meredith Giuliani et al. · Practical Radiation Oncology · 2017 · 466 citations · Full text

Medicine, Oncology, Radiation Oncology +17